$74.48 +0.41 (%) Baxter International Inc - NYSE

Dec. 19, 2014 | 04:00 PM

Partner Headlines

  1. Baxter Reports Filing of Form 10 Registration Statement Related to Planned Spinoff of Biopharma Unit

    Benzinga | Dec. 10, 2014 | 17:16PM EST
  2. Pfizer Spreading Its Wings Into A New Domain Of Life Sciences

    GuruFocus | Dec. 9, 2014 | 10:50AM EST
  3. Hot Drugmakers Build More Labs, Grab Space In Boston

    IBD | Dec. 4, 2014 | 16:47PM EST
  4. I think Zimmer Will Outperform S&P 500 Performance

    GuruFocus | Dec. 4, 2014 | 10:06AM EST
  5. Becton, Dickinson and Co. (BDX) Dividend Stock Analysis

    GuruFocus | Nov. 19, 2014 | 12:37PM EST
  6. Baxter tops in Q3 amid split-up

    IBD | Oct. 16, 2014 | 18:49PM EST
  7. Baxter Q3 Beats As Hemophilia Drugs Fend Off Rivals

    IBD | Oct. 16, 2014 | 15:07PM EST
  8. Earnings Scheduled For October 16, 2014

    Benzinga | Oct. 16, 2014 | 04:50AM EST
  9. UPDATE: Morgan Stanley Reiterates On Baxter International On Value Creation Through Spin

    Benzinga | Oct. 13, 2014 | 09:34AM EST
  10. UPDATE: Bank Of America Reiterates On Baxter International Inc. On Mixed Factors

    Benzinga | Oct. 6, 2014 | 07:40AM EST
  11. Baxter Gets Shot In The Arm From Rockwell Deal

    IBD | Oct. 3, 2014 | 18:09PM EST
  12. Benzinga's Top #PreMarket Gainers

    Benzinga | Oct. 3, 2014 | 08:44AM EST
  13. Medical Technology Company Offers Investment Opportunity

    GuruFocus | Sep. 25, 2014 | 16:00PM EST
  14. Stocks Gain While Dollar Reaches Highest Level Since 2010

    Benzinga | Sep. 24, 2014 | 17:03PM EST
  15. Dow Jumps 170 Points; Bed Bath & Beyond Shares Rise On Upbeat Results

    Benzinga | Sep. 24, 2014 | 15:54PM EST
  16. U.S. Stocks Rise; Accenture Shares Decline On Weak Forecast

    Benzinga | Sep. 24, 2014 | 13:17PM EST
  17. Markets Edge Lower; KB Home Posts Downbeat Results

    Benzinga | Sep. 24, 2014 | 10:49AM EST
  18. Morning Market Movers

    Benzinga | Sep. 24, 2014 | 09:40AM EST
  19. Baxter And Merrimack Pharmaceuticals Enter Into Exclusive Ex-U.S. Licensing Agreement to Develop And Commercialize Novel Cancer Compound MM-398

    Benzinga | Sep. 24, 2014 | 07:01AM EST
  20. FDA Approves Baxter's RIXUBIS For Treatment Of Children With Hemophilia B

    Benzinga | Sep. 15, 2014 | 09:01AM EST
  21. Abbott: A Brighter Future

    GuruFocus | Aug. 28, 2014 | 14:13PM EST
  22. Pfizer To Buy Baxter's Vaccines For $635 Million: The Positives & Negatives

    Benzinga | Aug. 5, 2014 | 09:16AM EST
  23. Halozyme Therapeutics Receives Favorable FDA Decision

    Benzinga | Jul. 31, 2014 | 14:45PM EST
  24. Merck, J&J, Baxter Provide Healthy Dividend Stream

    IBD | Jul. 30, 2014 | 19:01PM EST
  25. Stocks Mixed Despite Better-Than-Expected GDP

    Benzinga | Jul. 30, 2014 | 16:43PM EST
  26. Quarterly “Beats”: Bah, Here Are Real Growers

    YCharts | Jul. 29, 2014 | 21:32PM EST
  27. Diamond Hill Capital Comments on Baxter International Inc

    GuruFocus | Jul. 25, 2014 | 16:55PM EST
  28. Baxter Q2 Earnings Beat Estimates, But Guidance Soft

    IBD | Jul. 17, 2014 | 12:29PM EST
  29. Earnings Scheduled For July 17, 2014

    Benzinga | Jul. 17, 2014 | 05:08AM EST
  30. Hemophilia Drugs, Gambro Deal Boost Baxter's Growth

    IBD | Jul. 3, 2014 | 16:21PM EST
  31. Biogen Hemophilia Drugs Launch Into The Unknown

    IBD | Jun. 30, 2014 | 17:00PM EST
  32. Why I Bought Baxter International

    GuruFocus | Jun. 19, 2014 | 18:16PM EST
  33. Grifols Grows Into New Markets, Products Via Buyouts

    IBD | Jun. 6, 2014 | 17:58PM EST
  34. Cyberonics Shocks Investors With Weak Profit Guidance

    IBD | Jun. 4, 2014 | 12:44PM EST
  35. Becton, Dickinson and Co. (BDX) Dividend Stock Analysis

    GuruFocus | May. 30, 2014 | 12:32PM EST
  36. 7 Stocks Building Shareholder Returns with Higher Dividends

    GuruFocus | May. 12, 2014 | 12:17PM EST
  37. Medical Devices Face Onslaught Of Pricing Pressure

    IBD | May. 2, 2014 | 17:26PM EST
  38. Earnings Scheduled For April 17, 2014

    Benzinga | Apr. 17, 2014 | 05:24AM EST
  39. Baxter Announces Primary Efficacy Endpoint for Phase 3 Trial of BAX 11 Was Met, Will File for Approval in US Before End of '14

    Benzinga | Apr. 16, 2014 | 08:50AM EST
  40. 4 Top Stocks in the Medical Device Sector

    GuruFocus | Apr. 11, 2014 | 19:19PM EST
  41. Analysts Warm To Baxter's Split Announcement

    IBD | Mar. 31, 2014 | 17:38PM EST
  42. Alarming Spinoff: ADT Debt Soars, Stock Plunges

    YCharts | Mar. 30, 2014 | 19:32PM EST
  43. We Are Confident About Baxter's Plan to Create Two Separate Health Care Companies

    GuruFocus | Mar. 28, 2014 | 19:12PM EST
  44. For The Record

    IBD | Mar. 28, 2014 | 18:45PM EST
  45. Morgan Stanley Welcomes Shift in Sentiment on Baxter International

    Benzinga | Mar. 28, 2014 | 09:40AM EST
  46. Not Too Late to Buy Baxter, Jim Cramer Says

    Benzinga | Mar. 28, 2014 | 08:18AM EST
  47. Baxter To Split In 2 By 2015

    IBD | Mar. 27, 2014 | 18:51PM EST
  48. Market Wrap For March 27: Markets Lower Following Mixed Economic Data

    Benzinga | Mar. 27, 2014 | 17:39PM EST
  49. Mid-Afternoon Market Update: Inovio Rallies on Vaccine Award; Citigroup Remains Down on Stress Test Results

    Benzinga | Mar. 27, 2014 | 15:39PM EST
  50. Mid-Day Market Update: US Stocks Fall; Citigroup Shares Slip After Failed Stress Test Results

    Benzinga | Mar. 27, 2014 | 13:08PM EST
Trading Center